CRVO peer analysis
CervoMed (CRVO) against its competitors: price, today's move, 1-year return and market value side by side.
CRVO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACET Adicet Bio | $2.99 | -0.33% | -71.08% | $27.99M |
| ADAG Adagene | $2.13 | 3.90% | 25.29% | $80.19M |
| FBIO Fortress Biotech | $2.01 | 5.24% | -25.00% | $67.04M |
| GANX Gain Therapeutics | $1.11 | 2.78% | -58.58% | $49.42M |
| LITS Lite Strategy | $0.99 | 2.86% | -52.64% | $29.44M |
| NRXP NRX Pharmaceuticals | $2.32 | -4.92% | -6.83% | $100.45M |
| NTRB Nutriband | $5.94 | 3.12% | -2.46% | $72.20M |
| OSTX OS Therapies | $0.87 | -2.00% | -53.85% | $40.82M |
| VTVT vTv Therapeutics | $21.00 | -0.85% | -24.97% | $83.03M |
| XBIT XBiotech | $1.97 | 3.14% | -19.59% | $60.06M |
| CRVO CervoMed | $1.77 | 29.20% | -74.61% | $26.76M |
- CRVO's peers: ACET (Adicet Bio), ADAG (Adagene), FBIO (Fortress Biotech), GANX (Gain Therapeutics), LITS (Lite Strategy), NRXP (NRX Pharmaceuticals), NTRB (Nutriband), OSTX (OS Therapies).
Updated 2026-11-12 15:54 UTC